XML 85 R16.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Equity | 6 Months Ended
--- | ---
Jun. 30, 2013
Equity [Abstract] |
Equity | Equity Stock Incentive Plans The Company has three share-based compensation plans: the MiMedx Group, Inc. Assumed 2006 Stock Incentive Plan (the “2006 Plan”), the MiMedx Inc. 2007 Assumed Stock Plan (the “Assumed 2007 Plan”) and the MiMedx Group Inc. Amended and Restated Assumed 2005 Stock Plan (the “Assumed 2005 Plan”) which provide for the granting of qualified incentive and non-qualified stock options, stock appreciation awards and restricted stock awards to employees, directors, consultants and advisors. The awards are subject to a vesting schedule as set forth in each individual agreement. The Company intends to use only the 2006 Plan to make future grants. The number of assumed options under the Assumed 2005 Plan and Assumed 2007 Plan outstanding at June 30, 2013 totaled 375,000. On March 6, 2013, the Board of Directors approved 6,000,000 additional shares to be made available under the 2006 Plan, bringing the maximum number of shares of common stock which can be issued under the 2006 Plan to 22,500,000 at June 30, 2013. The shareholders approved the increase on May 9, 2013. Activity with respect to the stock options is summarized as follows:
| Number of Shares |  | Weighted- Average Exercise Price |  | Weighted- Average Remaining Contractual Term (in years) |  | Aggregate Intrinsic Value
Outstanding at January 1, 2013 | 13,614,135 |  |  | $ | 1.42 |  |  |  |  |
Granted | 3,024,500 |  |  | 5.09 |  |  |  |  |
Exercised | (489,197 | ) |  | 1.11 |  |  |  |  |
Unvested options forfeited | (179,167 | ) |  | 3.82 |  |  |  |  |
Vested options expired | (52,999 | ) |  | 1.11 |  |  |  |  |
Outstanding at June 30, 2013 | 15,917,272 |  |  | 2.10 |  |  | 7.9 |  | $ | 78,906,155 |
Vested at June 30, 2013 | 7,044,063 |  |  | 1.12 |  |  | 6.5 |  | $ | 41,809,325 |
Vested or expected to vest at June 30, 2013 (a) | 15,576,624 |  |  | $ | 2.10 |  |  | 7.9 |  | $ | 77,742,045 |
(a) | Includes forfeiture adjusted unvested shares.
The intrinsic value of the options exercised during the six months ended June 30, 2013, was approximately $2,345,000. Following is a summary of stock options outstanding and exercisable at June 30, 2013:
| Options Outstanding |  | Options Exercisable
Range of Exercise Prices | Number outstanding |  | Weighted- Average Remaining Contractual Term (in years) |  | Weighted- Average Exercise Price |  | Number Exercisable |  | Weighted- Average Exercise Price
$0.50 - $0.76 | 2,169,500 |  |  | 4.8 |  | $ | 0.67 |  |  | 2,169,500 |  |  | $ | 0.67 |
$0.87 - $1.35 | 6,814,572 |  |  | 8.1 |  | 1.19 |  |  | 3,356,198 |  |  | 1.18 |
$1.40 - $2.29 | 1,816,700 |  |  | 6.4 |  | 1.63 |  |  | 1,518,365 |  |  | 1.65 |
$2.33 - $3.75 | 2,164,500 |  |  | 9.2 |  | 2.75 |  |  | — |  |  | — |
$3.95 - $6.53 | 2,804,000 |  |  | 9.7 |  | 5.00 |  |  | — |  |  | — |
$6.60 - $6.75 | 148,000 |  |  | 9.9 |  | 6.61 |  |  | — |  |  | — |
| 15,917,272 |  |  | 7.9 |  | $ | 2.10 |  |  | 7,044,063 |  |  | $ | 1.12 |
Total unrecognized compensation expense related to granted stock options at June 30, 2013, was approximately $11,717,000 and is expected to be recognized over a weighted-average period of 2.4 years. The fair value of options granted by the Company is estimated on the date of grant using the Black-Scholes-Merton option-pricing model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the options. The term of employee options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term. The term for non-employee options is generally based upon the contractual term of the option. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term or contractual term as described. The assumptions used in calculating the fair value of options using the Black-Scholes-Merton option-pricing model are set forth in the following table:
| Six months ended June 30,
| 2013 |  | 2012
Expected volatility | 62.15-64.27% |  |  | 57.3 - 57.6% |
Expected life (in years) | 5.5 - 6 |  |  | 6 |
Expected dividend yield | — |  |  | — |
Risk-free interest rate | 0.85-1.13% |  |  | 1.48-2.24% |
The weighted-average grant date fair value for options granted during the six months ended June 30, 2013 was approximately $2.95 . During the first six months of 2013, the Company granted 280,000 shares of restricted stock with a weighted-average grant date fair value of $5.23 which vest over a 1 to 3 year period. As of June 30, 2013, there was approximately $1,267,000 of total unrecognized stock-based compensation related to time-based, nonvested restricted stock. That expense is expected to be recognized on a straight-line basis over a weighted-average period of 2.5 years. For the three and six months ended June 30, 2013 and 2012, the Company recognized stock-based compensation as follows:
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2013 |  | 2012 |  | 2013 |  | 2012
Cost of products sold | $ | 72,669 |  |  | $ | 29,479 |  |  | $ | 122,831 |  |  | $ | 53,489 |
Research and development | 122,789 |  |  | 75,610 |  |  | 198,767 |  |  | 147,130 |
Selling, general and administrative | 1,306,989 |  |  | 480,126 |  |  | 2,165,641 |  |  | 885,581 |
| $ | 1,502,447 |  |  | $ | 585,215 |  |  | $ | 2,487,239 |  |  | $ | 1,086,200 |
Warrants The Company grants common stock warrants in connection with equity share purchases by investors as an additional incentive for providing long term equity capital to the Company and as additional compensation to consultants and advisors. The warrants are granted at negotiated prices in connection with the equity share purchases and at the market price of the common stock in other instances. The warrants have been issued for terms of five years. Following is a summary of the warrant activity for the six months ended June 30, 2013:
| Number of Warrants |  | Weighted- Average Exercise Price per Warrant
Warrants outstanding at January 1, 2013 | 3,129,168 |  |  | $ | 1.04 |
Warrants exercised: |  |  |
Contingent warrants related to private placement of common stock | (62,500 | ) |  | 0.01 |
Callable warrants | (266,666 | ) |  | 1.50 |
Other | (668,000 | ) |  | 1.15 |
Warrants outstanding at June 30, 2013 | 2,132,002 |  |  | $ | 0.98 |
Warrants may be exercised in whole or in part by:
• | notice given by the holder accompanied by payment of an amount equal to the warrant exercise price multiplied by the number of warrant shares being purchased; or
• | election by the holder to exchange the warrant (or portion thereof) for that number of shares equal to the product of (a) the number of shares issuable upon exercise of the warrant (or portion) and (b) a fraction, (x) the numerator of which is the market price of the shares at the time of exercise minus the warrant exercise price per share at the time of exercise and (y) the denominator of which is the market price per share at the time of exercise.
These warrants are not mandatorily redeemable, and do not obligate the Company to repurchase its equity shares by transferring assets or issuing a variable number of shares. The warrants require that the Company deliver shares as part of a physical settlement or a net-share settlement, at the option of the holder, and do not provide for a net-cash settlement. All of our warrants are classified as equity as of June 30, 2013 and December 31, 2012.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph 64, 65, A240 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 40 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Statement of Position (SOP) -Number 93-6 -Paragraph 53 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration